• 【For Investors】R&D Day Video
  • 香港伋理服务器ip免费
  • 香港免费伋理服务器国外app
  • 国外伋理服务器ip免费

Featured Stories

Who We Are

极光wpn

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.
read more ...

Investor Relations

极光wpn

Completion of Payment Concerning Disposal of Treasury Shares as Restricted Share-Based Remuneration has been announced.
read more ...

Corporate Governance Report has now been updated.
read more ...

Disposal of Treasury Shares as Restricted Share-Based Remuneration has been announced.
read more ...

ASCO 2023 Highlight materials are now available.
read more ...

Convocation Notice of the 15th Ordinary General Meeting of Shareholders is now available.
read more ...

FY2023 Q4 financial results are now available.
read more ...

Featured News

2023.07.27
Corporate
Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062 PDF
2023.07.22
Corporate
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan PDF
2023.07.21
香港伋理服务器ip免费
Daiichi Sankyo Announces Phase 3 Study Results for Prasugrel Antiplatelet Agent in Thrombotic Stroke Patients 在线伋理服务器免费网页版
2023.07.10
香港伋理服务器ip免费
Daiichi Sankyo Announces Participation in AMR Action Fund PDF
2023.07.07
香港免费伋理服务器国外app
EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer PDF
2023.07.02
R&D
Daiichi Sankyo Expands DS-1062 Study to Include Patients with Triple Negative Breast Cancer PDF
2023.06.29
R&D
Daiichi Sankyo Provides Update on CHMP Review of Pexidartinib, a CSF1R Inhibitor for the Treatment of Patients with TGCT 国外伋理服务器ip免费
2023.06.26
Corporate
Daiichi Sankyo Announces Start of Discussions with AstraZeneca Regarding Supply in Japan of Novel Corona Virus Vaccine PDF

在线伋理服务器免费网页版

2023.06.15
CSR
Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 13th Annual Clinical Pharmacology Research Award
2023.06.12
香港免费伋理服务器国外app
R&D Activities for COVID-19 Vaccines and Therapeutics
2023.04.22
CSR
Daiichi Sankyo Announces Collaborative Research with DNDi on Drugs for Neglected Tropical Diseases
2023.04.13
CSR
Our Company’s Efforts to Limit the Spread of the Virus that Causes COVID-19

极光wpn


极光wpn


Who We Are

Our People

Partnerships

国外伋理服务器ip免费

Daiichi Sankyo Library

极光wpn


Our Approach

Pipeline

Open Innovation

TaNeDS Global

极光wpn


Media Relations

Investor Relations

极光wpn


CSR TOP

Responsible Corporate Activities

CSR Activities in Six Priority Areas

在线伋理服务器免费网页版

香港伋理服务器ip免费

Reports

蜂鸟电脑加速器官网  阿里云搭酸酸乳教程  iPhone有免费的梯子吗  嘿快点VPN  老王加速下载器下载官网  黑洞加速器安卓版官网  快联加速下载